Parisotto Shannon M's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed Oct 7, 2026
- Accession no.
- 0001952784-26-000003
- Filed
- Oct 7, 2026, 8:32 PM ET
- Trade date
- Oct 5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $302.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parisotto Shannon MCIK 0001952784 | Officer (CEVP, Disc & Safety Assessment) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Common Stock | MOption exerciseAcquired | +981 | $208.44 | +$204,479.64 | 5,788 | Direct | |
| Oct 5, 2026 | Common Stock | SSaleDisposed | −981 | $308.44 | −$302,579.64 | 4,807 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Common Stock | MOption exerciseDisposed | −981 | $0.00 | $0 | 2,944 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.